Sacutan 49mg / 51mg Tablet

Sacutan 49mg/51mg Tablet is a combination medication containing Sacubitril & Valsartan as its active ingredients. Sacubitril is a neprilysin inhibitor, while Valsartan is an angiotensin II receptor blocker (ARB). Together, they work synergistically to reduce blood pressure and improve heart function in patients with heart failure.

Uses:

Sacutan 49mg/51mg Tablet is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults. It is used to reduce the risk of cardiovascular death and hospitalization for heart failure. Sacubitril inhibits the enzyme neprilysin, which increases the levels of beneficial peptides that promote vasodilation and diuresis, while Valsartan blocks the effects of angiotensin II, leading to vasodilation and decreased sodium retention.

Dosage:

The recommended dosage of Sacutan 49mg/51mg Tablet is one tablet taken orally twice daily. The dosage may be titrated based on individual patient characteristics and tolerability. It is important to follow the prescribed dosage regimen for optimal therapeutic effect. Patients should not exceed the recommended dosage without consulting their healthcare provider.

Side Effects:

Common side effects associated with Sacutan 49mg/51mg Tablet may include hypotension (low blood pressure), hyperkalemia (high potassium levels), dizziness, fatigue, and renal dysfunction. These side effects are usually mild and transient. However, individuals should inform their healthcare provider if they experience any persistent or severe symptoms. In rare cases, more serious side effects such as angioedema or renal failure may occur.

Precautions:

Before using Sacutan 49mg/51mg Tablet, individuals should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication should be used with caution in patients with renal impairment or hyperkalemia. Regular monitoring of renal function, electrolytes, and blood pressure is recommended during treatment. Pregnant or breastfeeding women should consult a healthcare professional before using this medication.